The company have significantly advanced its progress of a novel solution for amyloid heart disease, leveraging Attruby. Preliminary patient data suggests promising outcomes for those diagnosed by the severe disease. https://biotech822353.sharebyblog.com/41996196/firm-advances-attr-cm-treatment-using-attruby